Breast Cancer

News

Hypothesis for mechanism of action of IL-34 in TNBC
21 Aug 2020
Hokkaido University scientists have shown that Interleukin-34 is a prognostic marker and drug target for Triple Negative Breast Cancer.

Events

Sorry, no events coming up for this topic.

Researchers

Sorry, no researchers coming up for this topic.

Giants in history

Sorry, no researchers coming up for this topic.